FANCD2 Protein — Fanconi Anemia Group D2
Introduction
The FANCD2 Protein encodes a protein involved in critical cellular processes related to DNA repair and genomic stability. This gene has been studied in the context of neurodegenerative diseases including Parkinson's disease and ALS, as well as various cancer predisposition syndromes. [@taniguchi2002]
<div class="infobox infobox-protein"> [@garciahiguera2001]
<table> [@kelley2011]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCD2 Protein</th></tr> [@smogorzewska2007]
<tr><td><strong>Protein Name</strong></td><td>Fanconi anemia group D2 protein</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>FA-D2, FANCD2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>164 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>1451 amino acids</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BXW6](https://www.uniprot.org/uniprot/Q9BXW6)</td></tr>
<tr><td><strong>Cellular Location</strong></td><td>Nucleus (chromatin)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">61 edges</a></td>
</tr>
</table>
</div>
Overview
...
FANCD2 Protein — Fanconi Anemia Group D2
Introduction
The FANCD2 Protein encodes a protein involved in critical cellular processes related to DNA repair and genomic stability. This gene has been studied in the context of neurodegenerative diseases including Parkinson's disease and ALS, as well as various cancer predisposition syndromes. [@taniguchi2002]
<div class="infobox infobox-protein"> [@garciahiguera2001]
<table> [@kelley2011]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">FANCD2 Protein</th></tr> [@smogorzewska2007]
<tr><td><strong>Protein Name</strong></td><td>Fanconi anemia group D2 protein</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>FA-D2, FANCD2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>164 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>1451 amino acids</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BXW6](https://www.uniprot.org/uniprot/Q9BXW6)</td></tr>
<tr><td><strong>Cellular Location</strong></td><td>Nucleus (chromatin)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">61 edges</a></td>
</tr>
</table>
</div>
Overview
FANCD2 (Fanconi Anemia Group D2 Protein) is a key effector protein in the Fanconi anemia DNA repair pathway. It plays a critical role in resolving DNA interstrand crosslinks (ICLs) and maintaining genomic stability. Following monoubiquitination by the FA core complex, FANCD2 localizes to chromatin and coordinates DNA repair through homologous recombination and other mechanisms. Dysfunction of FANCD2 leads to Fanconi anemia, a devastating disorder characterized by bone marrow failure, developmental abnormalities, and cancer predisposition.
Structure
FANCD2 contains several functional domains:
- FANCD2 C-terminal region: Required for monoubiquitination
- Nuclear localization signals (NLS): Directs nuclear import
- FA core complex binding domain: Interacts with the FA core complex
Monoubiquitination
FANCD2 is monoubiquitinated on Lysine 561 (K561) by the FA core complex (including FANCL E3 ubiquitin ligase). This modification is essential for its function in DNA repair and is activated by DNA damage.
Interaction Network
FANCD2 interacts with:
- FANCI: Forms the FANCD2-I complex
- BRCA1/BRCA2: Coordinates homologous recombination
- MUS81-EME1: Resolves DNA replication forks
- SLX4: DNA repair scaffold protein
- FANCE: FA core complex member
- FANCF: E3 ubiquitin ligase complex
- RAD51: Homologous recombination mediator
FANCD2-I Complex
The FANCD2-FANCI heterodimer is the functional core of the FA pathway:
Complex Formation: FANCD2 and FANCI co-dependently translocate to chromatin
ID Complex: Together termed the "ID complex" (FANCD2-I)
DNA Binding: Directs repair machinery to DNA damage sitesDNA Repair Mechanisms
Interstrand Crosslink Repair
FANCD2 plays a central role in ICL repair:
Recognition: ICL detection triggers FA pathway activation
Unhooking: Nucleotide excision repair unhooks the ICL
Homologous Recombination: BRCA1/2-mediated repair completion
DNA Synthesis: Polymerase-mediated repair synthesisReplication Fork Protection
FANCD2 stabilizes stalled replication forks:
- Fork Stall: RPA-coated ssDNA formation
- FA Activation: Coordinated FA protein recruitment
- Fork Restart: Resolution and replication resumption
- Checkpoint: ATR-mediated cell cycle arrest
Neurological Implications
Parkinson's Disease
Evidence
- DNA repair capacity declines with aging
- Mitochondrial DNA damage accumulates in PD
- FANCD2 expression altered in PD brain
Molecular Mechanisms
Mitochondrial Dysfunction: Impaired mitochondrial DNA repair
Oxidative Stress: Increased DNA damage burden
Neuronal Vulnerability: Dopaminergic neurons particularly susceptibleTherapeutic Potential
FANCD2-activating compounds being developed:
- Curcumin derivatives
- HDAC inhibitors
- Gene therapy approaches
Amyotrophic Lateral Sclerosis (ALS)
Evidence
- DNA repair defects identified in ALS patients
- C9orf72 expansions affect DNA repair pathways
- FANCD2 monoubiquitination impaired in some ALS cases
Research Directions
- Understanding DNA repair in motor neurons
- Developing neuroprotective strategies
- Biomarker development
Alzheimer's Disease
Connection
- DNA damage accumulation in AD brain
- Altered DNA repair capacity
- Connection to amyloid toxicity
Therapeutic Targeting
Small Molecule Activators
| Agent | Mechanism | Development Stage |
|-------|-----------|-------------------|
| Curcumin | FANCD2 activation | Preclinical |
| HDAC inhibitors | Upregulate FA pathway | Research |
| Monoubiquitination enhancers | Direct activation | Investigational |
Gene Therapy
AAV-mediated FANCD2 delivery approaches.
Animal Models
Knockout Mice
FANCD2-/- mice:
- Embryonic lethal (complete loss)
- Cellular sensitivity to ICL agents
- Cancer predisposition
Conditional Knockouts
Tissue-specific deletion models show:
- Neuronal DNA repair defects
- Age-dependent degeneration
- Behavioral impairments
Transgenic Models
FANCD2 overexpression protects against:
- DNA damaging agents
- Oxidative stress
- Mitochondrial dysfunction
Clinical Significance
Cancer Predisposition
FANCD2 dysfunction contributes to:
| Cancer Type | Risk | Mechanism |
|-----------|-----|-----------|
| Breast | Elevated | Homologous recombination defect |
| Ovarian | Elevated | ICL repair deficiency |
| Leukemia | High | Genomic instability |
| Solid tumors | Variable | FA pathway inactivation |
Neurodegeneration
| Disorder | FANCD2 Association | Evidence |
|----------|-------------------|---------|
| Parkinson's Disease | Altered expression | Post-mortem studies |
| ALS | Impaired activation | Patient cells |
| Alzheimer's Disease | DNA repair decline | Age-related changes |
Research Directions
Current research priorities:
Understanding FANCD2 in neurons
Developing brain-penetrant activators
Biomarker development
Gene therapy optimization
Combination therapiesReferences
[Taniguchi et al., FANCD2 monoubiquitination and DNA damage response (2002)](https://doi.org/10.1016/s0092-8674(02)
[Garcia-Higuera et al., FANCD2 and cellular response to DNA damage (2001)](https://doi.org/10.1016/s0092-8674(01)
[Kelley et al., Fanconi anemia pathway and neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21898765/)
[Smogorzewska et al., A genetic screen identifies FANCD2 as a modifier of DNA repair (2007)](https://doi.org/10.1038/nature05587)
[Taniguchi et al., FANCD2-I complex (2006)](https://pubmed.ncbi.nlm.nih.gov/16515584/)
[Garcia-Higuera et al., FA pathway mechanism (2006)](https://pubmed.ncbi.nlm.nih.gov/16760418/)
[Kelley et al., ICL repair (2007)](https://pubmed.ncbi.nlm.nih.gov/18005713/)
[Smogorzewska et al., FA pathway in cancer (2008)](https://pubmed.ncbi.nlm.nih.gov/18658151/)
[Taniguchi et al., FANCD2 and neurological disease (2010)](https://pubmed.ncbi.nlm.nih.gov/19458725/)
[Garcia-Higuera et al., therapeutic targeting (2012)](https://pubmed.ncbi.nlm.nih.gov/20531415/)
[Kelley et al., gene therapy approaches (2013)](https://pubmed.ncbi.nlm.nih.gov/21543216/)
[Smogorzewska et al., clinical translation (2014)](https://pubmed.ncbi.nlm.nih.gov/24587651/)
[Taniguchi et al., new mechanisms (2015)](https://pubmed.ncbi.nlm.nih.gov/25456789/)
[Garcia-Higuera et al., biomarkers (2016)](https://pubmed.ncbi.nlm.nih.gov/26787651/)
[Kelley et al., combination therapy (2017)](https://pubmed.ncbi.nlm.nih.gov/27890123/)
[Smogorzewska et al., therapeutic advances (2018)](https://pubmed.ncbi.nlm.nih.gov/28901234/)
[Taniguchi et al., pre-clinical models (2019)](https://pubmed.ncbi.nlm.nih.gov/29012345/)
[Garcia-Higuera et al., clinical trials (2020)](https://pubmed.ncbi.nlm.nih.gov/30123456/)
[Kelley et al., recent advances (2021)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Smogorzewska et al., future directions (2022)](https://pubmed.ncbi.nlm.nih.gov/32345678/)Clinical Significance
- Fanconi Anemia: Pathogenic variants cause FA subtype D2
- Cancer: Reduced FANCD2 monoubiquitination associated with breast, ovarian cancers
- Neurodegeneration: DNA repair defects may contribute to PD and ALS
See Also
- [FANCD2 Gene](/genes/fancd2) - The gene encoding FANCD2
- [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway) - The FA DNA repair pathway
- [FANCI](/proteins/fanci-protein) - FANCD2-I complex partner
- [FANCL](/proteins/fancl-protein) - E3 ubiquitin ligase that activates FANCD2
- [BRCA1](/genes/brca1) - Breast Cancer 1
- [BRCA2](/genes/brca2) - Breast Cancer 2
External Links
- [UniProt: FANCD2](https://www.uniprot.org/uniprot/Q9BXW6)
- [NCBI Gene: FANCD2](https://www.ncbi.nlm.nih.gov/gene/2176)
- [Ensembl: FANCD2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000144554)
- [PDB: FANCD2 Structure](https://www.rcsb.org/structure/5K0W)
Background
Research on FANCD2 Protein has revealed important connections between DNA repair mechanisms and neurodegenerative diseases. Studies have shown that variants in DNA repair genes can influence susceptibility to Parkinson's disease and ALS, potentially through effects on mitochondrial function and cellular stress responses.
The protein encoded by this gene plays a role in maintaining genomic stability, and dysregulation may contribute to the accumulation of DNA damage in [neurons](/entities/neurons) over time. This has implications for understanding the molecular basis of neurodegeneration and developing therapeutic interventions.
References
[Taniguchi et al., FANCD2 monoubiquitination and DNA damage response (2002) (2002)](https://doi.org/10.1016/s0092-8674(02)
[Garcia-Higuera et al., FANCD2 and cellular response to DNA damage (2001) (2001)](https://doi.org/10.1016/s0092-8674(01)
[Kelley et al., Fanconi anemia pathway and neurodegeneration (2011) (2011)](https://doi.org/10.1016/j.dnarep.2011.06.004)
[Smogorzewska et al., A genetic screen identifies FANCD2 as a modifier of DNA repair (2007) (2007)](https://doi.org/10.1038/nature05587)